Autonomix medical, inc. (nasdaq: amix) commences trading on nasdaq

Company developing potential breakthrough technology for the nervous system initially targeting multi-billion-dollar pancreatic cancer market the woodlands, tx., jan. 29, 2024 (globe newswire) -- autonomix medical, inc. (nasdaq: amix) (“autonomix” or the “company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, announced its common stock will begin trading on the nasdaq today, monday, january 29, 2024 at approximately 10:30 am est under the ticker symbol “amix.
AMIX Ratings Summary
AMIX Quant Ranking